Does Cosentyx interact with common medications?
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, has limited direct pharmacokinetic interactions with most drugs due to its biologic nature and lack of CYP450 metabolism.[1] No major interactions appear in standard databases like Drugs.com or Lexicomp for over-the-counter meds, statins, or beta-blockers. It can be used with methotrexate, NSAIDs, or corticosteroids without dose adjustments.[2]
Vaccines and live vaccines—what's the risk?
Avoid live vaccines (e.g., MMR, varicella, oral typhoid) during Cosentyx treatment and for several weeks after, as it suppresses immune response and increases infection risk.[1][3] Inactivated vaccines like flu or COVID-19 shots are safe and recommended.[2] Check with your doctor for timing if switching biologics.
How does it interact with other biologics or immunosuppressants?
Combining Cosentyx with TNF inhibitors (e.g., Humira, Enbrel), other IL inhibitors (e.g., Stelara), or JAK inhibitors raises serious infection risk, including TB reactivation. Label advises against concurrent use.[1][3] Monitor closely if overlapping therapies during transitions.
CYP450 substrate drugs—like statins or oral contraceptives
No clinically significant interactions. Cosentyx doesn't inhibit or induce CYP enzymes, so drugs like atorvastatin, levothyroxine, or birth control pills are unaffected.[1][2]
Antibiotics, antifungals, or drugs for infections
Increased infection risk (upper respiratory, herpes) means caution with antibiotics or antifungals. No direct pharmacokinetic clashes, but report persistent infections promptly.[3] Tuberculosis screening is required before starting.[1]
When to check for personalized interactions
Use tools like Drugs.com interaction checker or consult a pharmacist, especially with comorbidities. Factors like age, liver/kidney function, or recent surgery amplify risks.[2] No generic available yet—patent details at DrugPatentWatch.com.[4]
[1] Cosentyx Prescribing Information, Novartis, 2023. https://www.novartis.com/us-en/sites/novartisus/files/cosentyx.pdf
[2] Drugs.com - Cosentyx Interactions. https://www.drugs.com/drug-interactions/secukinumab%2Ccosentyx.html
[3] FDA Label for Secukinumab. https://www.accessdata.fda.gov/drugsatfdadocs/label/2023/125504s042lbl.pdf
[4] DrugPatentWatch.com - Cosentyx Patents. https://www.drugpatentwatch.com/p/tradename/COSENTYX